Top Markets
#1 Trillions Trillions +4,372.65%
#2 Ozapay Ozapay +38.33%
#3 Aria.AI Aria.AI +21.33%
#4 TRIA TRIA +14.00%
#5 Zano Zano +12.45%
#6 Osaka Protocol Osaka Protocol +12.26%
#7 DeXe DeXe +11.85%
#8 River Pts River Pts +11.61%
#9 pippin pippin +9.94%
#10 Janction Janction +9.42%
Coin of the day
Trillions Trillions
Settings
Language
ENGLISH
Currency
USD
Theme
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Rank in Stocks #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Share Price
$0.28545656
Market Cap
$4.50M
Change (1 day)
5.97%
Change (1 year)
0.00%
Country
FR
Trade Acticor Biotech SAS (ALACT)

Category

Healthcare
Dividend yield history for Acticor Biotech SAS (ALACT)
Acticor Biotech SAS (stock symbol: ALACT) dividend yield (TTM) as of 2022-12-31: 0.00%
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Acticor Biotech SAS (ALACT) from 2010 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
Dividend yields (TTM) for similar companies or competitors
Company Dividend Yield Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.72%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
0.48%
US
UCB SA UCB SA
UCB SA
UCB.BR
0.48%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.03%
AU